Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
122.60
+0.09 (0.07%)
Oct 29, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $10.19 billion as of October 29, 2026. It is the 2,111th most valuable company in the world and the 768th biggest in the United States. Its market cap has increased by 130.16% in one year.
Market Cap
10.19B
Enterprise Value
8.62B
1-Year Change
130.16%
Global Rank
Country Rank
#768 United States
Category
ChartMarket Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $10.19B, an increase of 1,121.63%. That is a compound annual growth rate of 49.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 10.19B | 63.77% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.71B |
| Madrigal Pharmaceuticals | 10.17B |
| Twist Bioscience | 10.02B |
| Vaxcyte | 9.55B |
| Caris Life Sciences | 9.51B |
| Krystal Biotech | 9.49B |
| Corcept Therapeutics | 9.47B |
| Spyre Therapeutics | 9.26B |